Antiretroviral Therapy as HIV Prevention: Status and Prospects

被引:67
|
作者
Mayer, Kenneth H. [1 ,2 ,3 ]
Venkatesh, Kartik K. [2 ]
机构
[1] Miriam Hosp, Div Infect Dis, Dept Med, Providence, RI 02906 USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[3] Fenway Inst Fenway Hlth, Boston, MA USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL RISK BEHAVIOR; TENOFOVIR DISOPROXIL FUMARATE; NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS; DRUG-RESISTANCE; HETEROSEXUAL TRANSMISSION; GENITAL-TRACT; SEMINAL PLASMA; PREEXPOSURE PROPHYLAXIS; REVERSE-TRANSCRIPTASE;
D O I
10.2105/AJPH.2009.184796
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
As antiretroviral treatment of HIV infection has become increasingly accessible, attention has focused on whether these drugs can used for prevention because of increased tolerability of newer medications, decreased cost, and the limitations of other approaches. We review the status of antiretroviral HIV prevention, including chemoprophylaxis, as well as the effects of treatment of infected individuals on prevention. It is possible that the life-saving agents that have transformed the natural history of AIDS can be a critical component of HIV prevention efforts, but their ultimate role in affecting HIV transmission dynamics remains to be defined. (Am J Public Health. 2010;100:1867-1876. doi:10.2105/AJPH.2009.184796)
引用
收藏
页码:1867 / 1876
页数:10
相关论文
共 50 条
  • [41] Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative
    Rodger, Alison J.
    Bruun, Tina
    Vernazza, Pietro
    Collins, Simon
    Estrada, Vicente
    Van Lunzen, Jan
    Corbelli, Giulio M.
    Phillips, Andrew N.
    Lundgren, Jens D.
    ANTIVIRAL THERAPY, 2013, 18 (03) : 285 - 287
  • [42] HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART)
    Madi, Deepak
    Gupta, Parul
    Achappa, Basavaprabhu
    Bhaskaran, Unnikrishnan
    Ramapuram, John T.
    Rao, Satish
    Mahalingam, Soundarya
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (08) : OC14 - OC16
  • [43] Antiretroviral therapy and HIV prevention in India: Modeling costs and consequences of policy options
    Over, Mead
    Marseille, Elliot
    Sudhakar, Kurapati
    Gold, Julian
    Gupta, Indrani
    Indrayan, Abhaya
    Hira, Subhash
    Nagelkerke, Nico
    Rao, Arni S. R. Srinivasa
    Heywood, Peter
    SEXUALLY TRANSMITTED DISEASES, 2006, 33 (10) : S145 - S152
  • [44] Cholesterol, vitamin D and cardiovascular prevention in HIV patients treated with antiretroviral therapy
    Mascitelli, Luca
    Pezzetta, Francesca
    Goldstein, Mark R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (03) : 441 - 442
  • [45] Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy
    Jones, Amanda J.
    Eke, Uzoamaka A.
    Eke, Ahizechukwu C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 837 - 848
  • [46] Antiretroviral therapy for prevention of HIV infection: New clues from an animal model
    Cohen, Myron S.
    Kashuba, Angela D. M.
    PLOS MEDICINE, 2008, 5 (02) : 190 - 192
  • [47] ANTIRETROVIRAL PREVENTION OF HIV PERINATAL TRANSMISSION
    LALLEMANT, M
    LECOEUR, S
    TARANTOLA, D
    MANN, J
    ESSEX, M
    LANCET, 1994, 343 (8910): : 1429 - 1430
  • [48] Antiretroviral resource allocation for HIV prevention
    Singh, Jerome Amir
    AIDS, 2013, 27 (06) : 863 - 865
  • [49] Trial of antiretroviral for HIV prevention on hold
    Ahmad, K
    LANCET INFECTIOUS DISEASES, 2004, 4 (10): : 597 - 597
  • [50] Inhibitors of the HIV protease for therapy of AIDS - Current status and future prospects
    Korant, BD
    MEDICAL ASPECTS OF PROTEASES AND PROTEASE INHIBITORS, 1997, 15 : 113 - 117